IA
TMCI icon

IFP Advisors’s Treace Medical Concepts TMCI Stock Holding History

IFP Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35K Buy
1,092
+91
+9% +$250 ﹤0.01% 3871
2026
Q1 		$1.34K Buy
1,001
+24
+2% +$48 ﹤0.01% 4101
2025
Q4 		$2.39K Buy
977
+932
+2,071% +$4.05K ﹤0.01% 3775
2025
Q3 		$302 Sell
45
-196
-81% -$1.28K ﹤0.01% 4304
2025
Q2 		$1.42K Buy
+241
New +$1.57K ﹤0.01% 4059
2025
Q1 		– Sell
-2
Closed -$15 – 4624
2024
Q4 		$15 Buy
+2
New +$13 ﹤0.01% 4496

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

IFP Advisors's TMCI Position: Q2 2026 in Review

IFP Advisors increased its Treace Medical Concepts (TMCI) stake by 9.1% in Q2 2026, buying an estimated $250 and bringing the position to 1,092 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3871.

IFP Advisors first reported a position in TMCI in Q4 2024 and has held it in 6 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • IFP Advisors held 1,092 shares of Treace Medical Concepts worth $4.35K as of Q2 2026.
  • IFP Advisors bought 91 Treace Medical Concepts shares in Q2 2026, an estimated $250.
  • Treace Medical Concepts made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3871 holding.
  • IFP Advisors first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 6 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.